The Vitality Lab Podcast

Aaran Vijayakumaran

A New Podcast Hosted by Aaran Vijayakumaran Ph.D, a Scientist at Stanford University Curious Together | Exploring science, mind, and meaning Welcome to The Vitality Lab — a podcast about the science of being human. This show blends physiology, psychology, and philosophy to explore what it means to grow, adapt, and live with intention. It's a space for people who ask why we are the way we are, and what we can do about it. We don’t claim to have the answers — but we believe in asking better questions. Whether it’s the stress of endurance, the complexity of the mind, or the search for meaning, this podcast invites you to think more deeply about the forces shaping our lives. Because the world is full of rich information — and we’re here to make sense of it, together. New episodes weekly. For the curious. For the seekers. For those still becoming.

Episodes

  1. Microbiome in Parkinson’s: Biomarker, Bystander, or Therapeutic Target? | Dr. Frederick Clasen

    5D AGO

    Microbiome in Parkinson’s: Biomarker, Bystander, or Therapeutic Target? | Dr. Frederick Clasen

    In this episode, we go beyond genetic and molecular narratives of Parkinson’s disease to explore a bold new frontier: the role of the microbiome as a biomarker, bystander, or therapeutic target in cognitive decline. My guest today is Dr Frederick Clasen, Research Associate at the Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London. Dr Clasen completed his undergraduate and master’s work in Bioinformatics and Biotechnology at the University of Pretoria before earning his PhD across the Francis Crick Institute and King’s College London, where he developed mathematical and genome-scale models of host and microbial metabolism. Dr Clasen is first author on a landmark 2025 study published in Gut Microbes that used shotgun metagenomics and machine learning to map both oral and gut microbiome changes across healthy controls and Parkinson’s patients with varying degrees of cognitive impairment. Their work reveals that microbes — and specifically oral microbes translocating to the gut with enriched virulence factors — may be linked to Parkinson’s cognitive decline via an oral-gut-brain axis, offering not just associations but mechanistic hypotheses and potential biomarkers. In this conversation we unpack: Why the microbiome may be more than a bystander in Parkinson’s diseaseWhat makes a microbial biomarker credible vs. noiseHow virulence factors and host metabolism may influence brain functionWhat it takes to move from correlation to testable mechanismThe real hurdles — and opportunities — for translating microbiome science into diagnostics and therapiesIf you’re a scientist, clinician, founder, or investor curious about where biology meets translation, this episode will sharpen how you think about mechanism, de-risking, and what truly counts as a target in complex human disease.

    1h 20m
  2. Can Fasting Reduce Inflammation? | Professor Clare Bryant

    FEB 8

    Can Fasting Reduce Inflammation? | Professor Clare Bryant

    Professor Clare Bryant is a Professor of Innate Immunity at the University of Cambridge and one of the world’s leading experts on inflammation, inflammasomes, and immune signalling. Her work focuses on how the immune system detects danger — from infections to misfolded proteins — and how chronic inflammation contributes to ageing and neurodegenerative disease. Her research has helped shape our understanding of the NLRP3 inflammasome, a key inflammatory pathway now implicated in conditions such as Alzheimer’s disease, Parkinson’s disease, obesity, cardiovascular disease, and atherosclerosis. In this episode, we explore what inflammation actually is, why we need it to survive — and when it quietly turns from protector to problem. We unpack: Why chronic inflammation (“inflammaging”) rises with ageHow inflammatory pathways are linked to brain health and neurodegenerationWhat the NLRP3 inflammasome is — explained simplyWhy fasting produces surprising changes in inflammatory markersHow a lipid called arachidonic acid can switch off inflammasome activityWhy common drugs like aspirin and ibuprofen may have anti-inflammatory effects beyond pain reliefWhether fasting could realistically play a role in managing chronic inflammationThe difference between mouse studies and human biology, and why it mattersWhy biomarkers like ASC “specks” may be more useful than lifestyle hypeThis is a deep but accessible conversation about fasting, inflammation, and brain health, grounded in human data and real biology — not wellness trends. We also discuss the limits of fasting, potential risks, and why personalised approaches to diet and inflammation will likely define the future. If you’re interested in longevity, neuroscience, immune biology, or how lifestyle intersects with disease risk, this episode will change how you think about inflammation.

    41 min
  3. GLP-1 Drugs, the Brain, and Mental Health | Dr Riccardo De Giorgi

    JAN 11

    GLP-1 Drugs, the Brain, and Mental Health | Dr Riccardo De Giorgi

    Dr Riccardo De Giorgi, MD, DPhil, MRCPsych, is a Clinical Lecturer in Psychiatry at the University of Oxford and an Honorary Consultant in General Adult Psychiatry at Oxford Health NHS Foundation Trust. He teaches psychiatry and psychopharmacology, leads experimental medicine research, and focuses on repurposing immuno-metabolic drugs — including GLP-1 receptor agonists — for cognitive and mental disorders. In this episode, we explore GLP-1 receptor agonists (GLP-1RAs) — medications originally developed for diabetes and obesity — and their emerging relevance to psychiatry and brain health. Recent analyses, including work led by Dr De Giorgi, review preclinical and clinical evidence suggesting these drugs may influence cognitive processes, reward pathways, mood regulation, and inflammatory mechanisms implicated in conditions such as depression, addiction, Alzheimer’s disease, and other psychiatric or neurocognitive disorders. We discuss: How GLP-1 signalling works in the body and the brainWhy psychiatrists are increasingly interested in GLP-1RAs beyond metabolic effectsThe current evidence for psychiatric and cognitive benefits (and limitations)Mechanistic challenges in translating animal findings to humansThe importance of stratifying patients and integrating biomarkers in future researchThis episode strips away hype to uncover what science currently supports — and what remains an open question — about the psychiatric potential of GLP-1 receptor agonists.

    52 min
  4. Gum Disease, Fasting-Mimicking Diets & Inflammation | Professor Luigi Nibali

    JAN 4

    Gum Disease, Fasting-Mimicking Diets & Inflammation | Professor Luigi Nibali

    Professor Luigi Nibali is an award-winning specialist periodontist who has been keeping gums healthy and saving teeth for more than 15 years. He is a Professor of Periodontology at King’s College London (Guy’s Hospital) and a leading clinician–scientist in gum disease and oral inflammation. Trained in dentistry in Italy, Luigi Nibali completed an MSc and PhD at the UCL Eastman Dental Institute, where his research focused on the genetic and inflammatory drivers of aggressive periodontitis. His work spans clinical periodontology, systemic inflammation, and the links between oral health and cardiovascular disease, diabetes, cancer, and neurodegeneration. In this episode, we break down what periodontitis actually is, why it often develops silently, and why bleeding gums are an early warning sign that shouldn’t be ignored. We explore how chronic oral inflammation can contribute to whole-body inflammation, including its relationship with markers such as C-reactive protein (CRP). We then discuss Luigi’s recent feasibility study using a fasting-mimicking diet alongside standard periodontal treatment — what the protocol involved, what they observed, and why diet may help regulate inflammation without adding more medication. This conversation connects oral health, diet, inflammation, and long-term disease risk, with practical insights on prevention and why gum health remains one of the most overlooked pillars of overall health. Highlights • Bleeding gums aren’t normal — they signal chronic inflammation • Periodontitis often progresses silently for years • Oral inflammation can increase systemic inflammatory burden (CRP) • Diet quality may influence gum disease severity • Fasting-mimicking diets show early promise as an adjunct therapy Topics Periodontitis • Oral inflammation • Systemic inflammation • CRP Oral microbiome • Fasting-mimicking diets • Diet & inflammation • Prevention & oral hygiene • Lifestyle and metabolic health

    43 min

About

A New Podcast Hosted by Aaran Vijayakumaran Ph.D, a Scientist at Stanford University Curious Together | Exploring science, mind, and meaning Welcome to The Vitality Lab — a podcast about the science of being human. This show blends physiology, psychology, and philosophy to explore what it means to grow, adapt, and live with intention. It's a space for people who ask why we are the way we are, and what we can do about it. We don’t claim to have the answers — but we believe in asking better questions. Whether it’s the stress of endurance, the complexity of the mind, or the search for meaning, this podcast invites you to think more deeply about the forces shaping our lives. Because the world is full of rich information — and we’re here to make sense of it, together. New episodes weekly. For the curious. For the seekers. For those still becoming.